Despite recent layoffs and cutbacks, diagnostic testing giant Quest Diagnostics (NYSE: DGX) is a good long-term buy for investors looking for safety because it has been extending its already impressive reach in the United States.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,